在波多诺伏使用激素避孕的女性的绝对心血管风险。
Absolute cardiovascular risk of women using hormonal contraception in Porto-Novo.
作者信息
Sonou Arnaud, Ogoudjobi Mathieu, Adjagba Philippe Mahouna, Houehanou Corine, Aniglé Richard, Codjo Léopold, Hounkponou Murielle, Bognon Rosaire, Assani Salimatou, Amoussou-Guénou Daniel, Houénassi Dèdonougbo Martin
机构信息
Departmental University Hospital of l'Ouémé-Plateau, Porto-Novo, Bénin. Email:
Departmental University Hospital of l'Ouémé-Plateau, Porto-Novo, Bénin.
出版信息
Cardiovasc J Afr. 2018;29(2):e1-e4. doi: 10.5830/CVJA-2018-016. Epub 2018 Mar 27.
INTRODUCTION
The purpose of this work was to determine the absolute cardiovascular risk (ACVR) of women using hormonal contraception in Porto-Novo.
METHODS
We carried out a descriptive, cross-sectional study, including women at the time of renewal of a hormonal contraceptive method. Blood pressure, fasting venous blood glucose level, body mass index and electrocardiographic left ventricular hypertrophy were studied. The determination of ACVR was dual based on the World Health Organisation (WHO/ISH) and the European Society of Cardiology (ESC/ESH) models.
RESULTS
The mean age of the women was 35.3 ± 8.2 years. Blood pressure and blood glucose levels were high in 24 and 1.5% of cases, respectively. Left ventricular hypertrophy was present in 7.1% of cases. A high ACVR was found in 5.2% of these women, using the ESC/ESH model.
CONCLUSION
The occurrence of women with high ACVR in this group raises the problem of cardiovascular eligibility to the contraceptive method used.
引言
本研究旨在确定科托努使用激素避孕的女性的绝对心血管风险（ACVR）。
方法
我们开展了一项描述性横断面研究，纳入激素避孕方法续用期的女性。研究了血压、空腹静脉血糖水平、体重指数和心电图左心室肥厚情况。基于世界卫生组织（WHO/ISH）和欧洲心脏病学会（ESC/ESH）模型对ACVR进行双重测定。
结果
女性的平均年龄为35.3±8.2岁。血压和血糖水平升高的病例分别占24%和1.5%。7.1%的病例存在左心室肥厚。使用ESC/ESH模型，这些女性中有5.2%的ACVR较高。
结论
该组中ACVR较高的女性的出现引发了所使用避孕方法的心血管适用性问题。
Zotero 插件